Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (551-560 of 627) with videos related to

Pageof 63
Sort By:
Journal of the American Heart Association|August 5, 2022
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE TrialJing-Wei Li, Clare Arnott, Hiddo J L Heerspink, et al.
The New England Journal of Medicine|November 14, 2019
Large-Scale Assessment of a Smartwatch to Identify Atrial FibrillationMarco V Perez, Kenneth W Mahaffey, Haley Hedlin, et al.
Journal of the American College of Cardiology|June 3, 2026
Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup AnalysesKatherine R Tuttle, George L Bakris, Florian M M Baeres, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
Thrombosis and Haemostasis|January 10, 2014
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic SubstudyRobert F Storey, Jayaprakash Kotha, Susan S Smyth, et al.
American Heart Journal|December 25, 2015
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarctionSean D Pokorney, Christina Radder, Phillip J Schulte, et al.
American Heart Journal|February 22, 2025
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)C Michael Gibson, M Cecilia Bahit, Roxana Mehran, et al.
JAMA Cardiology|July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary SyndromePaul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.
Stroke|May 17, 2019
Stroke in Patients With Peripheral Artery DiseaseBrad J Kolls, Shelly Sapp, Frank W Rockhold, et al.
American Journal of Nephrology|December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsMeg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.
Pageof 63

Showing results (551-560 of 627) with videos related to

Sort By:
Pageof 63
Journal of the American Heart Association|August 5, 2022
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE TrialJing-Wei Li, Clare Arnott, Hiddo J L Heerspink, et al.
The New England Journal of Medicine|November 14, 2019
Large-Scale Assessment of a Smartwatch to Identify Atrial FibrillationMarco V Perez, Kenneth W Mahaffey, Haley Hedlin, et al.
Journal of the American College of Cardiology|June 3, 2026
Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup AnalysesKatherine R Tuttle, George L Bakris, Florian M M Baeres, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
Thrombosis and Haemostasis|January 10, 2014
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic SubstudyRobert F Storey, Jayaprakash Kotha, Susan S Smyth, et al.
American Heart Journal|December 25, 2015
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarctionSean D Pokorney, Christina Radder, Phillip J Schulte, et al.
American Heart Journal|February 22, 2025
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)C Michael Gibson, M Cecilia Bahit, Roxana Mehran, et al.
JAMA Cardiology|July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary SyndromePaul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.
Stroke|May 17, 2019
Stroke in Patients With Peripheral Artery DiseaseBrad J Kolls, Shelly Sapp, Frank W Rockhold, et al.
American Journal of Nephrology|December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsMeg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.
Pageof 63